Abstract:BACKGROUND:Accumulating evidence has demonstrated the immunomodulatory effects of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in rheumatoid arthritis and the tumor microenvironment, besides its known capacity of specifically inducing the apoptosis of cancer cells. Mice are common available animal models for studying the roles of TRAIL. However, mice express only a single TRAIL receptor (mTRAILR) with an intracellular death domain, in contrast to the two TRAIL receptors (TRAILR1 and TRAILR2) in humans. Moreover, human TRAIL binds weakly to mTRAILR, whereas mouse TRAIL has a high affinity for human TRAIL-Rs. Therefore, we considered that murine TRAIL would be more suitable than human TRAIL for exploring the immunoregulatory effect of TRAIL in immunocompetent mice or when using mouse cells as the target. To our knowledge, the detailed method for the production of recombinant murine TRAIL has not been reported.OBJECTIVE:In this study, we aimed to design and express two soluble forms of murine TRAIL and verify the properties of the protein.METHODS:Recombinant murine TRAILs were expressed in Escherichia coli BL21 (DE3, and Nichelating affinity chromatography was used for protein purification. SDS-PAGE, GDS-PAGE and HPLC were applied to analyze the protein structure. The cytotoxicity of our purified murine TRAILs was evaluated in the TRAIL-sensitive human breast cancer ZR-75-30 cells and murine breast cancer 4T1 cells. Finally, validation of the tumor-killing ability of the murine protein in vivo.RESULTS:Two soluble forms of murine TRAILs (mT_N99 and mT_N188) were purified and demonstrated with high purity and trimeric structure. In addition, Zn2+ supplement was essential to produce soluble murine TRAILs in E.coli BL21 (DE3). The two purified soluble mTRAILs showed similar cytotoxicity to cancer cells, moreover, mT_N99 also showed a good anti-tumor effect in vivo and is more suitable for the treatment of murine tumor models.CONCLUSION:A production approach for recombinant murine TRAIL was determined, which covered the design of shortened forms, expression, purification and characterization.

Functional Solubilization of Aggregation-Prone TRAIL Protein Facilitated by Coexpressing with Protein Isoaspartate Methyltranferase

Fed-batch Production of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) in Soluble Form in Escherichia Coli and Its Purification and Characterization.

Trimeric Coiled-Coil Domain of Human Pulmonary Surfactant Protein D Enhances Zinc-Binding Ability and Biologic Activity of Soluble TRAIL.

Engineering and refolding of a novel trimeric fusion protein TRAIL-collagen XVIII NC1

Purification and Characterization of Recombinant Strail Expressed in Escherichia Coli

Production of Soluble Murine TRAILs in Escherichia Coli with Zn2+ Supplementation

Expression, purification, and in vitro refolding of soluble tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).

Hetero-modification of TRAIL trimer for improved drug delivery and in vivo antitumor activities

Expression, Purification and Characterization of Heterotrimeric Forms of Strail Using a Polycistronic Expression Vector.

Preliminary studies on in vivo refolding of TRAIL inclusion bodies

Prokaryltic Expression and Renaturation of Recmbinant Human Extracellular TRAIL Fragment

Soluble Expression of TNF-Related Apoptosis-Inducing Ligand and Optimization of Its Purification Conditions

Antitumor Activity of Recombinant Soluble Human TRAIL

A simplified method for the efficient purification and refolding of recombinant human TRAIL

Recombinant expression and anti-tumor effects of single-chain TRAIL in E. coli

Improvement of Pharmacokinetic Profile of TRAIL via Trimer-Tag Enhances its Antitumor Activity in vivo

Production and Antitumor Activity of Soluble Human TRAIL

High-level production of soluble tumor necrosis factor-related apoptosis-inducing ligand (Apo2L/TRAIL) in high-density cultivation of recombinant Escherichia coli using a combined feeding strategy

[Cloning, Expression and Purification of Human TNF-related Apoptosis-Inducing Ligand in Escherichia Coli].

Refolding and purification of Apo2L/TRAIL produced as inclusion bodies in high-cell-density cultures of recombinant Escherichia coli

GroEL/ES Mediated the in Vivo Recovery of TRAIL Inclusion Bodies in Escherichia Coli.